Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AGMB-129 by AgomAb Therapeutics for Crohn's Disease (Regional Enteritis): Likelihood of Approval
AGMB-129 is under clinical development by AgomAb Therapeutics and currently in Phase II for Crohn's Disease (Regional Enteritis). According to...